Seeing Is Believing
FStar Therapeutics's activity chart (see below) currently has 23 price targets and 26 ratings on display.
Analysts average stock forecasts to be materialized ratio is 42.27% with an average time for these price targets to be met of 233.55 days.
Most recent stock forecast was given by DAINA GRAYBOSCH from LEERINK on 30-Jan-2023. First documented stock forecast 01-May-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 30-Jan-2023
$7
3 years 9 months 2 days ago
(30-Jan-2023)
1/2 (50%)
$0.61 (9.55%)
256
Buy Since 01-Mar-2021
$7
$-0.12 (-1.69%)
4 years 3 months 17 days ago
(15-Jul-2022)
1/2 (50%)
$0.85 (13.82%)
235
Buy Since 09-Jun-2021
$28
$20.88 (293.26%)
$8
5 years 4 months 23 days ago
(09-Jun-2021)
1/2 (50%)
$21.03 (301.72%)
23
Buy
$30
$22.88 (321.35%)
5 years 6 months 16 days ago
(16-Apr-2021)
0/1 (0%)
$19.86 (195.86%)
Hold Since 29-Jan-2020
$6.8
6 years 6 months 30 days ago
(02-Apr-2020)
2/5 (40%)
$1.48 (27.82%)
70
What is FSTX (FStar Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on FSTX (FStar Therapeutics)?
Which analyst has the most public recommendations on FSTX (FStar Therapeutics)?
Which analyst is the currently most bullish on FSTX (FStar Therapeutics)?
Which analyst is the currently most reserved on FSTX (FStar Therapeutics)?